Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 449809Erstellt: 24. Oktober 2026

Ferrous oxide

https://huagongshe.com/de/chemical/449809

Molekülstruktur von Ferrous oxide

Identifikatoren & physikalische Daten

CAS No.1345-25-1
SummenformelFeO
Durchschnittliche Molmasse71,84 g/mol
Monoisotopische Masse71,92985 g/mol
SMILES[Fe+2].[O-2]
InChIKeyVBMVTYDPPZVILR-UHFFFAOYSA-N
PubChem CID449809
DTXSIDDTXSID1041976

Chemische & physikalische Eigenschaften

Polarare Oberfläche (TPSA)1
H-Brücken-Donoren0
H-Brücken-Akzeptoren1
Frei drehbare Bindungen0
Schwere Atome2
Formalladung0
Komplexität0
Dichte6.0 g/cu cm5.7 g/cm³6 @25 °C
Color/FormBlack cubic crystals
LöslichkeitPractically insol in water and alkaliesreadily sol in acidsInsoluble in alcoholSolubility in water: none
Schmelzpunkt1377 °C1360 °C
BrechungsindexINDEX OF REFRACTION: 2.23
Physical DescriptionLarge CrystalsOther SolidBlack solid[ICSC] Black odorless powderInsoluble in water[MSDSonline]BLACK SOLID IN VARIOUS FORMS.
Other Experimental PropertiesEasily oxidized by airit is strong base and readily absorbs carbon dioxide

Sicherheit & Vorschriften

Regulatorische InformationenChemical: Iron oxide (FeO)Iron oxide (FeO) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Iron oxide (FeO) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)Iron oxide (FeO): Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Weitere SicherheitsinformationenIMAP assessments - Iron oxide (FeO): Environment tier I assessmentIMAP assessments - Iron oxide (FeO): Human health tier I assessment
BrandgefahrenCombustible under specific conditions.
BrandpotenzialFerrous oxide is spontaneously flammable in air.The oxide (prepared at 300 °C) burns in air above 200 °C, while the finely divided oxide prepared by reduction may be pyrophoric at ambient temperature. That prepared by thermal decomposition under vacuum of iron(II)oxalate is also pyrophoric.
GefahrenübersichtChronic inhalation of dust can result in siderosis[ICSC] An irritant[MSDSonline] See Iron oxide (Fe2O3).
Special ReportsJoint FAO/WHO Expert Committee on Food AdditivesWHO Food Additives Ser 6: Iron oxides and hydrated iron oxides (1975). Available from: http://www.inchem.org/documents/jecfa/jecmono/v06je23.htm as of September 14, 2004.
Chemical DangersDepending on the preparation method, the substance may ignite spontaneously on contact of finely divided powder with air or may burn on contact with air when heated above 200 °C. The substance readily absorbs carbon dioxide.
Bundesrichtlinien für TrinkwasserEPA 300 ug/L /Iron/
Skin, Eye, and Respiratory IrritationsIf inhaled, iron is a local irritant to the lung and gastrointestinal tract. /Iron compounds/
Hazardous Reactivities and IncompatibilitiesFluorine does not act in the cold on ferrous oxide, but with gentle heat a reaction sets in with incandescence.When ferrous oxide, prepared at 300 °C, is heated in sulfur dioxide, the mass becomes incandescent.Easily oxidized by air. It is a strong base and readily absorbed /carbon dioxide/.The oxide incandesces when heated in sulfur dioxide.For more Hazardous Reactivities and Incompatibilities (Complete) data for FERROUS OXIDE (7 total), please visit the HSDB record page.
BrandbekämpfungIn case of fire in the surroundings, use appropriate extinguishing media.
Erste-Hilfe-MaßnahmenFresh air, rest.Rinse and then wash skin with water and soap.First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then refer for medical attention.Rinse mouth.
BrandbekämpfungsverfahrenIn case of fire in the surroundings: all extinguishing agents allowed.
ReinigungsverfahrenSweep spilled substance into covered containersif appropriate, moisten first to prevent dusting. Wash away remainder with plenty of water.
EntsorgungsverfahrenSRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air qualitypotential migration in soil or watereffects on animal, aquatic, and plant lifeand conformance with environmental and public health regulations.
Verschüttetes entsorgenPersonal protection: particulate filter respirator adapted to the airborne concentration of the substance. Sweep spilled substance into covered containers. If appropriate, moisten first to prevent dusting. Wash away remainder with plenty of water.
Preventive MeasuresSRP: The scientific literature for the use of contact lenses in industry is conflicting. The benefit or detrimental effects of wearing contact lenses depend not only upon the substance, but also on factors including the form of the substance, characteristics and duration of the exposure, the uses of other eye protection equipment, and the hygiene of the lenses. However, there may be individual substances whose irritating or corrosive properties are such that the wearing of contact lenses would be harmful to the eye. In those specific cases, contact lenses should not be worn. In any event, the usual eye protection equipment should be worn even when contact lenses are in place.All ... /iron/ preparations should be kept in child-proof bottles. /Iron preparations/
Eye PreventionWear safety spectacles.
Inhalation RiskA harmful concentration of airborne particles can be reached quickly when dispersed, especially if powdered.
Skin PreventionProtective gloves.
Exposure PreventionPREVENT DISPERSION OF DUST!
Ingestion PreventionDo not eat, drink, or smoke during work.
ÖkotoxizitätswerteLC50 Gambusia affinis (Western mosquitofish) >10,000 mg/L/24, 48, 96 hrstatic
Signs and SymptomsCough.
Natural Pollution SourcesHematite, goethite, and lepidocrocite /are minerals that/ contain ferrous oxide
Human Toxicity Excerpts/HUMAN EXPOSURE STUDIES/ Collection of iron dust in lungs ... has been termed siderosis... Siderosis is considered benign condition and does not progress to fibrosis. /Iron oxide fume//CASE REPORTS/ ...Two women underwent dermopigmentation on the face in a beauty institution to create pseudo-freckles. Definite macular hyperpigmentation occurred with dyschromia in both subjects./CASE REPORTS/ ...Histopathologic studies /were performed/ on a series of three eyelid specimens, including two by a previously undescribed multi-needle pigment delivery system. Light microscopy revealed the epidermis to be pigment-free and the dermis to contain pigment in clumps. Transmission electron microscopy (EM) demonstrated that the pigment was largely in macrophages. Energy-dispersive x-ray micro-analysis showed that in addition to iron and talc, titanium particles were also present. These findings suggest that the pigment is tolerated by the eyelid despite the fact that current pigments are contaminated.
Non-Human Toxicity Excerpts/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ Dogs were injected with iron oxide iv each week for 6-10 weeks, until a total of 0.5 or 1.0 g/kg of iron was administered to each of two dogs. The four dogs were then followed for seven years. Hepatic function tests and biopsies of liver, spleen, pancreas and other organs were performed. Hemochromatosis was not induced, but blindness, with lesions similar to retinitis pigmentosa, developed in all dogs. No control group was included in this study. /Iron oxide, nos//LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Ten males and three female /minks/ were fed iron oxide as 0.75% of their diet. Reproduction, whelping, and lactation were seen to be similar to that of controls. Six male and four female pups were then continued on the iron oxide diet until pelting (165 days). Although fur quality and growth were normal, these mink had acute nephrosis and hepatosis at pelting. /Iron oxide, nos//LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Ten dogs were fed from 1-9 years on diets containing iron oxide colorant at 570 mg/lb. Daily consumption was estimated at 428 mg/dog. Two Labradors fed one year had loose droppings, otherwise there were no adverse effects observed. /Iron oxide, nos/
Evidence for CarcinogenicityA4: Not classifiable as a human carcinogen. /Iron oxide (Fe2O3)/
Antidote and Emergency TreatmentBasic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if necessary. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for shock and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . /Iron and Related Compounds/Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious. Monitor cardiac rhythm and treat arrhythmias if necessary ... . Start an IV with lactated Ringer's /SRP: "To keep open", minimal flow rate/. Watch for signs of fluid overload. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Iron and Related Compounds/Maintain an open airway and assist ventilation if necessary. Treat shock caused by hemorrhagic gastrointestinitis aggressively with intravenous crystalloid fluids, and replace blood if needed. Patients are often markedly hypovolemic owing to gastrointestinal losses and third spacing of fluids into the intestinal wall and interstitial space. Treat coma, seizures, and metabolic acidosis if they occur. For seriously intoxicated victims (eg, shock, severe acidosis, and/or serum iron > 500-600 mcg/dL) administer deferoxamine. Monitor the urine for the urine for the characteristic orange or pink deferoxamine-iron complex. Therapy may be stopped when the urine returns to normal or when the serum iron level decreases to the normal range. Prolonged deferoxamine has been associated with adult respiratory distress syndrome and Yersinia sepsis.Activated charcoal is not effective. Ipecac is not recommended, because it can aggravate iron-induced gastrointestinal irritation and interfere with whole bowel irrigation. Consider gastric lavage if product was a liquid formulation or tablets were chewed. Do-not use phosphate-containing solutions for lavagethese may result in life-threatening hypernatremia, hyperphosphatemia, and hypocalcemia. Bicarbonate and deferoxamine lavage are of doubtful efficacy. Deferoxamine lavage is not effective and may enhance iron absorption. Whole-bowel irrigation is very effective for ingested tablets and may be considered first-line treatment, especially if large numbers of tablets are visible on plain abdominal x-ray. Massive ingestions may lead to concretions or bezoars. Repeated or prolonged whole-bowel irrigation may remove tablets. Endoscopy or surgical gastrotomy is rarely required.Hemodialysis and hemoperfusion are not effective for removing iron but may be necessary to remove iron-deferoxamine complex in patients with renal failure. Exchange transfusion is occasionally used for massive pediatric ingestions but is of questionable efficacy.
Non-Human Toxicity ValuesLD50 Rat oral >15 g/kg /Iron oxide, nos/LD50 Mouse oral >15 g/kg /Iron oxide, nos/LD50 Rat ip >15 g/kg /Iron oxide, nos/